Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
Misonix, Inc. (NASDAQ: MSON) has announced that it will report its fiscal 2021 second-quarter financial results on February 4, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Misonix, Inc. (NASDAQ: MSON) has announced that it will report its fiscal 2021 second-quarter financial results on February 4, 2021, after market close. The company will hold a conference call and webcast at 4:30 p.m. ET to discuss these results, which is open to the public. Interested parties can access the call by dialing 866-248-8441 domestically, or 323-289-6576 internationally, using conference ID 2793331. A replay of the webcast will be available for 30 days on Misonix's website.
Details
News Market Reaction – MSON
The recorded move for MSON in the trading session of this news was -0.52%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 second quarter financial results after the market closes on Thursday, February 4, 2021. The Company will host a conference call and webcast at 4:30 p.m. ET that day to review the results. Both the call and webcast are open to the general public.
To access the conference call, interested parties may dial 866-248-8441 (domestic) or 323-289-6576 (international) conference ID 2793331. Participants may also listen to a live webcast of the call through the “Events and Presentations” section under “Investor Relations” on Misonix’s website at www.misonix.com. A webcast replay will be available for 30 days following the live event at www.misonix.com.
Please call five minutes in advance to ensure that you are connected. Questions and answers will be taken only from participants on the conference call. For the webcast, please allow 15 minutes to register, download and install any necessary software.
About Misonix, Inc.
Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company's web site at www.misonix.com.
| Contact: | |
| Joe Dwyer Chief Financial Officer Misonix, Inc. 631-927-9113 | Norberto Aja, Jennifer Neuman JCIR 212-835-8500 or mson@jcir.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.